bupropion has been researched along with Neuralgia in 6 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion is a specific inhibitor of neuronal noradrenaline reuptake and a weak inhibitor of dopamine reuptake, which shows some promise in the treatment of neuropathic pain." | 6.46 | Bupropion for the treatment of neuropathic pain. ( Moradimehr, A; Shah, TH, 2010) |
| "Drug effects on formalin-induced mechanical allodynia were evaluated for comparison." | 5.43 | Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. ( Leitl, MD; Negus, SS, 2016) |
| "Forty-one nondepressed patients with neuropathic pain spent 6 weeks in each phase in random order and received identical tablets of 150 mg bupropion SR or placebo." | 2.70 | Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. ( Davis, B; Semenchuk, MR; Sherman, S, 2001) |
| "Bupropion is a specific inhibitor of neuronal noradrenaline reuptake and a weak inhibitor of dopamine reuptake, which shows some promise in the treatment of neuropathic pain." | 2.46 | Bupropion for the treatment of neuropathic pain. ( Moradimehr, A; Shah, TH, 2010) |
| "Drug effects on formalin-induced mechanical allodynia were evaluated for comparison." | 1.43 | Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. ( Leitl, MD; Negus, SS, 2016) |
| "We hypothesized that bupropion inhibits neuropathic pain by increasing noradrenaline and dopamine in the spinal cord." | 1.42 | The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. ( Hoshino, H; Mieda, R; Nakajima, K; Obata, H; Saito, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, H | 1 |
| Obata, H | 1 |
| Nakajima, K | 1 |
| Mieda, R | 1 |
| Saito, S | 1 |
| Leitl, MD | 1 |
| Negus, SS | 1 |
| Hawley, P | 1 |
| Shah, TH | 1 |
| Moradimehr, A | 1 |
| Katz, J | 1 |
| Pennella-Vaughan, J | 1 |
| Hetzel, RD | 1 |
| Kanazi, GE | 1 |
| Dworkin, RH | 1 |
| Semenchuk, MR | 1 |
| Sherman, S | 1 |
| Davis, B | 1 |
1 review available for bupropion and Neuralgia
| Article | Year |
|---|---|
Bupropion for the treatment of neuropathic pain.
Topics: Analgesics, Non-Narcotic; Bupropion; Chronic Disease; Controlled Clinical Trials as Topic; Dopamine | 2010 |
2 trials available for bupropion and Neuralgia
| Article | Year |
|---|---|
A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cross-Over Studies; Del | 2005 |
Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cross-Over Studies; Delayed-Action Preparations; Dopamine | 2001 |
3 other studies available for bupropion and Neuralgia
| Article | Year |
|---|---|
The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Bupropion; Dopamine; Dopamine Uptake Inhibi | 2015 |
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Bupropion; Depression; Disease Models, Animal; Dose-Respons | 2016 |
Nontricyclic antidepressants for neuropathic pain #187.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Duloxetine Hydrochloride; Humans | 2009 |